article

1. Cellular Heterogeneity of Activated Primary Human Macrophages and Associated Drug-Gene Networks: From Biology to Precision Therapeutics..  Circulation.  148:1459-1478. 2023
2. A single institute validation study comparing the international chronic ocular graft-versus-host disease consensus group diagnostic criteria with clinical parameters..  The ocular surface.  12-14. 2021
3. Eyelid blood vessel and meibomian gland changes in a sclerodermatous chronic GVHD mouse model..  The ocular surface.  328-341. 2021
4. A Novel Spectral Annotation Strategy Streamlines Reporting of Mono-ADP-ribosylated Peptides Derived from Mouse Liver and Spleen in Response to IFN-γ..  Molecular & cellular proteomics : MCP.  21:-. 2021
5. Systems Approach to Discovery of Therapeutic Targets for Vein Graft Disease: PPARα Pivotally Regulates Metabolism, Activation, and Heterogeneity of Macrophages and Lesion Development..  Circulation.  143:2454-2470. 2021
6. Senescence-associated secretory phenotype promotes chronic ocular graft-vs-host disease in mice and humans..  FASEB journal : official publication of the Federation of American Societies for Experimental Biology.  34:10778-10800. 2020
7. The impact of PARPs and ADP-ribosylation on inflammation and host-pathogen interactions..  Genes & development.  34:341-359. 2020
8. Cluster of differentiation 30 expression in lacrimal gland and conjunctival tissues in patients with Sjögren's syndrome: Case series..  Medicine.  98:-. 2019
9. Commensal microflora in human conjunctiva; characteristics of microflora in the patients with chronic ocular graft-versus-host disease..  The ocular surface.  17:265-271. 2019